Genexine (XKRX:095700) Other Operating Expense : ₩8,821 Mil (TTM As of Mar. 2024)

View and export this data going back to 2009. Start your Free Trial

What is Genexine Other Operating Expense?

Genexine's Other Operating Expense for the three months ended in Mar. 2024 was ₩3,472 Mil. Its Other Operating Expense for the trailing twelve months (TTM) ended in Mar. 2024 was ₩8,821 Mil.

Genexine's quarterly Other Operating Expense declined from Sep. 2023 (₩2,449 Mil) to Dec. 2023 (₩452 Mil) but then increased from Dec. 2023 (₩452 Mil) to Mar. 2024 (₩3,472 Mil).

Genexine's annual Other Operating Expense increased from Dec. 2021 (₩13,826 Mil) to Dec. 2022 (₩13,925 Mil) but then declined from Dec. 2022 (₩13,925 Mil) to Dec. 2023 (₩8,051 Mil).

Genexine Other Operating Expense Historical Data

The historical data trend for Genexine's Other Operating Expense can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Genexine Other Operating Expense Chart

Genexine Annual Data

Trend

Dec14

Dec15

Dec16

Dec17

Dec18

Dec19

Dec20

Dec21

Dec22

Dec23

Other Operating Expense

Get a 7-Day Free Trial

7,495.71

6,757.04

13,826.39

13,924.90

8,051.38

Genexine Quarterly Data
	Jun19	Sep19	Dec19	Mar20	Jun20	Sep20	Dec20	Mar21	Jun21	Sep21	Dec21	Mar22	Jun22	Sep22	Dec22	Mar23	Jun23	Sep23	Dec23	Mar24
Other Operating Expense	Get a 7-Day Free Trial															2,701.76	2,448.55	2,449.15	451.91	3,471.86

Genexine Other Operating Expense Calculation

GuruFocus uses a standardized financial statement format for all companies. For non-financial companies, GuruFocus lists Selling, General, & Admin. Expense, , Research & Development, and Other Operating Expense under the "Total Operating Expense" section.

Other Operating Expense sometimes includes:
Restructuring, and merger
Acquisition related and other
Litigation settlement charge
Other (too numerous to list)

Some companies can and do choose to report each of these items separately. Yet, there are a variety of Other Operating Expense which are simply too numerous to list.

Other Operating Expense for the trailing twelve months (TTM) ended in Mar. 2024 adds up the quarterly data reported by the company within the most recent 12 months, which was ₩8,821 Mil.

Genexine Other Operating Expense Related Terms

Thank you for viewing the detailed overview of Genexine's Other Operating Expense provided by GuruFocus.com. Please click on the following links to see related term pages.

Genexine (XKRX:095700) Business Description

Industry

GURUFOCUS.COM » STOCK LIST » Healthcare » Biotechnology » Genexine Inc (XKRX:095700) » Definitions » Other Operating Expense

Comparable Companies

Traded in Other Exchanges

N/A

Address

700 Daewangpangyo-ro, Gyeonggi-do, Korea Bio Park Building B, Bundang-gu, Seongnam-si, KOR, 13488

Website

http://www.genexine.com

Genexine Inc is a clinical-stage biotechnology company. It is focused on the development and commercialization of immunotherapeutics and next-generation long-acting biologics. Its primary technologies are Therapeutic DNA vaccine technology and Hyfc platform. The company's product pipeline includes products such as GX-H9, GX-E2, GX-G3, GX-G6, and Papitrol-188 among others.

Genexine (XKRX:095700) Headlines

No Headlines